A real‐world data analysis of the impact of clonal hematopoiesis of indeterminate potential on therapeutic efficacy and adverse events of immune checkpoint inhibitors

Takamasa Fujita, Naoya Ishibashi, Satoru Aoyama, Yumi Kobayashi, Takashi Kamatani, Yusuke Kinugasa, Sadakatsu Ikeda

Open source

DOI
10.1002/cncr.70398
Published
2026-05-29
Container
Cancer
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cncr.70398,
  title = {A real‐world data analysis of the impact of clonal hematopoiesis of indeterminate potential on therapeutic efficacy and adverse events of immune checkpoint inhibitors},
  author = {Takamasa Fujita and Naoya Ishibashi and Satoru Aoyama and Yumi Kobayashi and Takashi Kamatani and Yusuke Kinugasa and Sadakatsu Ikeda},
  year = {2026},
  journal = {Cancer},
  doi = {10.1002/cncr.70398},
  url = {https://doi.org/10.1002/cncr.70398}
}

RIS

TY  - JOUR
TI  - A real‐world data analysis of the impact of clonal hematopoiesis of indeterminate potential on therapeutic efficacy and adverse events of immune checkpoint inhibitors
AU  - Takamasa Fujita
AU  - Naoya Ishibashi
AU  - Satoru Aoyama
AU  - Yumi Kobayashi
AU  - Takashi Kamatani
AU  - Yusuke Kinugasa
AU  - Sadakatsu Ikeda
PY  - 2026
JO  - Cancer
DO  - 10.1002/cncr.70398
UR  - https://doi.org/10.1002/cncr.70398
ER  - 

APA

Fujita, T., Ishibashi, N., Aoyama, S., Kobayashi, Y., Kamatani, T., Kinugasa, Y., & Ikeda, S. (2026). A real‐world data analysis of the impact of clonal hematopoiesis of indeterminate potential on therapeutic efficacy and adverse events of immune checkpoint inhibitors. Cancer. https://doi.org/10.1002/cncr.70398

Source records